Clinical Trials on PK, PD, and Safety in Hong Kong
Total 8 results
-
The University of Hong KongHong Kong Jockey Club Charities Trust; Lok Sin Tong Benevolent Society, Kowloon and other collaboratorsRecruitingHypertension | Diabetes Mellitus, Type 2 | Medication Adherence | Polypharmacy | Medication Safety | High Risk MedicationsHong Kong
-
The University of Hong KongRecruitingImmunocompromised Patients | Intradermal Covid-19 Vaccine | Immungenicity and Safety | Randomized TrialHong Kong
-
Suzhou Kintor Pharmaceutical Inc,CompletedEfficacy and SafetyUnited States
-
University of California, Los AngelesNational Institute of Mental Health (NIMH)UnknownSexually Transmitted Diseases | HIV | Safe Sex | Disease Transmission, InfectiousUnited States
-
Gilead SciencesMerck Sharp & Dohme LLCRecruitingTriple Negative Breast Cancer | PD-L1 PositiveUnited States, Taiwan, Belgium, Australia, Austria, Israel, Spain, Italy, Korea, Republic of, Japan, France, Netherlands, Canada, Turkey, Germany, Malaysia, Singapore, United Kingdom, Hong Kong, Hungary, Mexico, Switzerland, Puerto... and more
-
Gilead SciencesRecruitingTriple Negative Breast Cancer | PD-L1 NegativeUnited States, Hong Kong, Belgium, Australia, Austria, Israel, Spain, Korea, Republic of, Taiwan, China, Japan, Netherlands, Brazil, Canada, Turkey, France, Germany, Malaysia, United Kingdom, Singapore, Hungary, Mexico, Italy, Switzer... and more
-
AbbVieCompletedParkinson's Disease (PD)United States, Australia
-
AstraZenecaPRA Health SciencesCompletedRecurrent or Metastatic PD-L1-positive Squamous Cell Carcinoma of the Head and NeckUnited States, Belgium, Canada, France, Spain, Korea, Republic of, Hungary, Malaysia, United Kingdom, Taiwan, Germany, Georgia, Israel, Czechia